Clinical Trials Directory

Trials / Completed

CompletedNCT00357916

Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design

A Randomized, Controlled Study to Evaluate the Sensitizing Potential of PEP005 Topical Gel (0.01% Concentration) in Healthy Volunteers Using a Repeat Insult Patch Test Design

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
200 (planned)
Sponsor
Peplin · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To determine the sensitisation potential of PEP005 Topical Gel (0.01% concentration) on normal skin To evaluate skin irritation

Detailed description

This is a repeat insult patch test study. On treatment days, the investigational product PEP005 Topical Gel (0.01% concentration) and vehicle control will be applied under open conditions to sites on the infrascapular region of the back 3 times weekly for 3 weeks (9 applications in total) during the induction phase. Following a rest period of approximatley 10-14 days, a single challenge application will be performed. Local tolerability will be assessed visually using an ordinal scoring system. If a cutaneous response observed in the challenge phase indicates possible sensitisation, or at the discretion of the investigator, a rechallenge will occur

Conditions

Interventions

TypeNameDescription
DRUGPEP005 Topical Gel (0.01% concentration)

Timeline

Start date
2006-06-01
Primary completion
2006-10-01
Completion
2006-10-01
First posted
2006-07-28
Last updated
2016-04-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00357916. Inclusion in this directory is not an endorsement.

Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Tes (NCT00357916) · Clinical Trials Directory